Blog
RSS FeedPosted by Michael Wonder on 27 Nov 2018
China pharma crackdown leads to flu vaccine shortage
26 November 2018 - Scarcity highlights lack of staff at regulator to inspect and approve vaccines. ...
Posted by Michael Wonder on 26 Nov 2018
Government orders urgent meningococcal vaccination programme for Northland
26 November 2018 - The NZ Government is launching an urgent immunisation programme to fight an outbreak of meningococcal disease ...
Posted by Michael Wonder on 21 Nov 2018
Request for proposals - supply of various vaccines and influenza vaccines
20 November 2018 - PHARMAC invites proposals for the supply of various vaccines and influenza vaccines in New Zealand. ...
Posted by Michael Wonder on 15 Nov 2018
Merck begins rolling submission of licensure application for V920 (rVSV∆G-ZEBOV-GP) to U.S. FDA
13 November 2018 - V920 is the Company’s investigational vaccine for Ebola Zaire. ...
Posted by Michael Wonder on 31 Oct 2018
FDA grants priority review for Sanofi's dengue vaccine candidate
31 October 2018 - The United States FDA has accepted a biologics license application for Sanofi Pasteur's dengue vaccine. ...
Posted by Michael Wonder on 25 Oct 2018
Fast-track flu vaccine raises hopes for quicker drugs approvals
24 October 2018 - Post-Brexit registrations could be ‘five months faster’, says medicines regulator. ...
Posted by Michael Wonder on 24 Oct 2018
Seqirus receives FDA approval of Afluria Quadrivalent (influenza vaccine) for people six months of age and older in the U.S.
17 October 2018 - Seqirus today announced the U.S. FDA has approved Afluria Quadrivalent (influenza vaccine) for use in people ...
Posted by Michael Wonder on 08 Oct 2018
Valneva announces FDA approval of accelerated Ixiario vaccination schedule
5 October 2018 - Valneva announced today that the U.S. FDA has approved an alternate Ixiaro immunisation schedule of two doses ...
Posted by Michael Wonder on 05 Oct 2018
FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old
5 October 2018 - The U.S. FDA today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) ...
Posted by Michael Wonder on 01 Oct 2018
SA Government’s free Meningococcal B vaccination program starts
1 October 2018 - A vaccine could have saved 18-year-old Jack Klemich from the meningococcal B disease that suddenly took ...
Posted by Michael Wonder on 27 Sep 2018
Statement by FDA Commissioner on preparations for the upcoming flu season and vaccinations
27 September 2018 - This week marks the official start of “flu season” for 2018-2019. ...
Posted by Michael Wonder on 26 Sep 2018
EMA takes issue with BMJ article on Pandemrix vaccine
27 September 2018 - A recent article in the BMJ suggested that one pandemic flu vaccine was less safe than ...
Posted by Michael Wonder on 24 Sep 2018
Free vaccine for teenagers amidst rise of deadly meningococcal disease
25 September 2018 - Teenagers across Australia will be given a free meningococcal vaccine to protect them against four strains ...
Posted by Michael Wonder on 20 Sep 2018
Pfizer granted FDA breakthrough therapy designation for 20 valent pneumococcal conjugate vaccine for the prevention of invasive disease and pneumonia in adults aged 18 years ands older
20 September 2018 - Breakthrough therapy designation designed by FDA to expedite the development and review of drugs and vaccines which ...
Posted by Michael Wonder on 23 Aug 2018
Insights from the agenda for the November 2018 PBAC meeting
24 August 2018 - The PBAC will consider 51 submissions at its next scheduled meeting in November. ...